Tag: Pneumonia
Macrolide-Resistant M. pneumoniae in All U.S. Regions
Prevalence of 13.2 percent in sample of 91 M. pneumoniae-positive specimens from six locations
Considerable Burden for Community-Acquired Pneumonia
Incidence of community-acquired pneumonia requiring hospitalization is highest in elderly
PCV13 Predicted to Be Cost Saving Versus PCV7
Although 13-valent pneumococcal vaccine is more costly than PCV7, net cost savings expected
Community-Acquired Pneumonia Confers Long-Term Risk
High risk of long-term adverse events versus general population, irrespective of age
Macrolide Resistance Doesn’t Impact Pneumonia Outcomes
Patients hospitalized with macrolide-resistant S. pneumoniae not more severely ill at presentation
ATS: Risk of Pneumonia Up With Inhaled Corticosteroids in COPD
Observational studies show reduction in odds of pneumonia-associated, all-cause mortality
DPP-4 Inhibitors Not Tied to Pneumonia Hospitalizations
Findings among new users of antidiabetic drugs from 2007 to 2012
Outcomes No Worse for Macrolide-Resistant Pneumonia
Macrolide-resistance has no effect on outcomes as a function of compliance with current tx guidelines
Interventions Up Blood Culture Ordering in Pediatric Pneumonia
Increase in blood cultures for kids hospitalized with community-acquired pneumonia; no impact on LOS
Real-Time Decision Support Tool Aids ER Pneumonia Patients
Post deployment, significantly lower mortality in patients with community-acquired pneumonia
